Skip to main content
Top
Published in: Journal of Clinical Immunology 2/2012

01-04-2012

Determination of Human Anticytokine Autoantibody Profiles Using a Particle-Based Approach

Authors: Li Ding, Allen Mo, Kamonwan Jutivorakool, Minjal Pancholi, Steven M. Holland, Sarah K. Browne

Published in: Journal of Clinical Immunology | Issue 2/2012

Login to get access

Abstract

Background

Anticytokine autoantibodies cause numerous human diseases, ranging from pure red cell aplasia to acquired immunodeficiencies. Rapid, simple, and affordable detection and monitoring of these antibodies is essential. We sought to develop a standardizable assay that is rapid, sensitive, and specific and able to simultaneously detect multiple anticytokine autoantibodies in small volumes (<10 μl).

Methods

We conjugated purified human cytokines to commercially available fluorescently labeled microspheres and tested them against sera from well-characterized subjects with at least one high-titer, disease-associated anticytokine autoantibody.

Results

Cytokine-conjugated microspheres efficiently and rapidly determined plasma concentration and IgG subclass of anticytokine autoantibodies in single or multiplex formats.

Conclusion

This particle-based multiplex assay can reproducibly characterize anticytokine autoantibodies. This efficient and inexpensive approach to diagnosing and monitoring anticytokine autoantibodies has clinical applications.
Literature
1.
go back to reference Browne SK, Holland SM. Immunodeficiency secondary to anticytokine autoantibodies. Curr Opin Allergy Clin Immunol. 2010;10(6):534–41.PubMedCrossRef Browne SK, Holland SM. Immunodeficiency secondary to anticytokine autoantibodies. Curr Opin Allergy Clin Immunol. 2010;10(6):534–41.PubMedCrossRef
2.
go back to reference Riches PL, McRorie E, Fraser WD, Determann C, van’t Hof R, Ralston SH. Osteoporosis associated with neutralizing autoantibodies against osteoprotegerin. N Engl J Med. 2009;361(15):1459–65.PubMedCrossRef Riches PL, McRorie E, Fraser WD, Determann C, van’t Hof R, Ralston SH. Osteoporosis associated with neutralizing autoantibodies against osteoprotegerin. N Engl J Med. 2009;361(15):1459–65.PubMedCrossRef
3.
go back to reference Borie R, Debray MP, Laine C, Aubier M, Crestani B. Rituximab therapy in autoimmune pulmonary alveolar proteinosis. Eur Respir J. 2009;33(6):1503–6.PubMedCrossRef Borie R, Debray MP, Laine C, Aubier M, Crestani B. Rituximab therapy in autoimmune pulmonary alveolar proteinosis. Eur Respir J. 2009;33(6):1503–6.PubMedCrossRef
4.
go back to reference Kavuru MS, Malur A, Marshall I, Barna BP, Meziane M, Huizar I, et al. An open-label trial of rituximab therapy in pulmonary alveolar proteinosis. Eur Respir J. 2011. doi:10.1183/09031936.00197710. Kavuru MS, Malur A, Marshall I, Barna BP, Meziane M, Huizar I, et al. An open-label trial of rituximab therapy in pulmonary alveolar proteinosis. Eur Respir J. 2011. doi:10.​1183/​09031936.​00197710.
5.
go back to reference Behler CM, Terrault NA, Etzell JE, Damon LE. Rituximab therapy for pure red cell aplasia due to anti-epoetin antibodies in a woman treated with epoetin-alfa: a case report. J Med Case Reports. 2009;3:7335.PubMedCrossRef Behler CM, Terrault NA, Etzell JE, Damon LE. Rituximab therapy for pure red cell aplasia due to anti-epoetin antibodies in a woman treated with epoetin-alfa: a case report. J Med Case Reports. 2009;3:7335.PubMedCrossRef
6.
go back to reference Macdougall IC, Rossert J, Casadevall N, Stead RB, Duliege AM, Froissart M, et al. A peptide-based erythropoietin-receptor agonist for pure red-cell aplasia. N Engl J Med. 2009;361(19):1848–55.PubMedCrossRef Macdougall IC, Rossert J, Casadevall N, Stead RB, Duliege AM, Froissart M, et al. A peptide-based erythropoietin-receptor agonist for pure red-cell aplasia. N Engl J Med. 2009;361(19):1848–55.PubMedCrossRef
7.
go back to reference Remmers EF, Cosan F, Kirino Y, Ombrello MJ, Abaci N, Satorius C, et al. Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Behcet’s disease. Nat Genet. 2010;42(8):698–702.PubMedCrossRef Remmers EF, Cosan F, Kirino Y, Ombrello MJ, Abaci N, Satorius C, et al. Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Behcet’s disease. Nat Genet. 2010;42(8):698–702.PubMedCrossRef
8.
go back to reference Fuja T, Hou S, Bryant P. A multiplex microsphere bead assay for comparative RNA expression analysis using flow cytometry. J Biotechnol. 2004;108(3):193–205.PubMedCrossRef Fuja T, Hou S, Bryant P. A multiplex microsphere bead assay for comparative RNA expression analysis using flow cytometry. J Biotechnol. 2004;108(3):193–205.PubMedCrossRef
9.
go back to reference Zheng Z, Luo Y, McMaster GK. Sensitive and quantitative measurement of gene expression directly from a small amount of whole blood. Clin Chem. 2006;52(7):1294–302.PubMedCrossRef Zheng Z, Luo Y, McMaster GK. Sensitive and quantitative measurement of gene expression directly from a small amount of whole blood. Clin Chem. 2006;52(7):1294–302.PubMedCrossRef
10.
go back to reference Bonfield TL, John N, Barna BP, Kavuru MS, Thomassen MJ, Yen-Lieberman B. Multiplexed particle-based anti-granulocyte macrophage colony stimulating factor assay used as pulmonary diagnostic test. Clin Diagn Lab Immunol. 2005;12(7):821–4.PubMed Bonfield TL, John N, Barna BP, Kavuru MS, Thomassen MJ, Yen-Lieberman B. Multiplexed particle-based anti-granulocyte macrophage colony stimulating factor assay used as pulmonary diagnostic test. Clin Diagn Lab Immunol. 2005;12(7):821–4.PubMed
11.
go back to reference Burbelo PD, Browne SK, Sampaio EP, Giaccone G, Zaman R, Kristosturyan E, et al. Anti-cytokine autoantibodies are associated with opportunistic infection in patients with thymic neoplasia. Blood. 2010;116(23):4848–58.PubMedCrossRef Burbelo PD, Browne SK, Sampaio EP, Giaccone G, Zaman R, Kristosturyan E, et al. Anti-cytokine autoantibodies are associated with opportunistic infection in patients with thymic neoplasia. Blood. 2010;116(23):4848–58.PubMedCrossRef
12.
go back to reference Patel SY, Ding L, Brown MR, Lantz L, Gay T, Cohen S, et al. Anti-IFN-gamma autoantibodies in disseminated nontuberculous mycobacterial infections. J Immunol. 2005;175(7):4769–76.PubMed Patel SY, Ding L, Brown MR, Lantz L, Gay T, Cohen S, et al. Anti-IFN-gamma autoantibodies in disseminated nontuberculous mycobacterial infections. J Immunol. 2005;175(7):4769–76.PubMed
13.
go back to reference Wood BA, O’Halloran KP, Vandewoude S. Development and validation of a multiplex microsphere-based assay for detection of domestic cat (Felis catus) cytokines. Clin Vaccine Immunol. 2011;18(3):387–92.PubMedCrossRef Wood BA, O’Halloran KP, Vandewoude S. Development and validation of a multiplex microsphere-based assay for detection of domestic cat (Felis catus) cytokines. Clin Vaccine Immunol. 2011;18(3):387–92.PubMedCrossRef
14.
go back to reference Sun M, Manolopoulou J, Spyroglou A, Beuschlein F, Hantel C, Wu Z, et al. A microsphere-based duplex competitive immunoassay for the simultaneous measurements of aldosterone and testosterone in small sample volumes: validation in human and mouse plasma. Steroids. 2010;75(13–14):1089–96.PubMedCrossRef Sun M, Manolopoulou J, Spyroglou A, Beuschlein F, Hantel C, Wu Z, et al. A microsphere-based duplex competitive immunoassay for the simultaneous measurements of aldosterone and testosterone in small sample volumes: validation in human and mouse plasma. Steroids. 2010;75(13–14):1089–96.PubMedCrossRef
15.
go back to reference Lindberg C, Bokarewa M. Rituximab for severe myasthenia gravis—experience from five patients. Acta Neurol Scand. 2010;122(4):225–8.PubMedCrossRef Lindberg C, Bokarewa M. Rituximab for severe myasthenia gravis—experience from five patients. Acta Neurol Scand. 2010;122(4):225–8.PubMedCrossRef
16.
go back to reference Bhol K, Mohimen A, Ahmed AR. Correlation of subclasses of IgG with disease activity in pemphigus vulgaris. Dermatology. 1994;189 Suppl 1:85–9.PubMedCrossRef Bhol K, Mohimen A, Ahmed AR. Correlation of subclasses of IgG with disease activity in pemphigus vulgaris. Dermatology. 1994;189 Suppl 1:85–9.PubMedCrossRef
17.
go back to reference Bhol K, Natarajan K, Nagarwalla N, Mohimen A, Aoki V, Ahmed AR. Correlation of peptide specificity and IgG subclass with pathogenic and nonpathogenic autoantibodies in pemphigus vulgaris: a model for autoimmunity. Proc Natl Acad Sci USA. 1995;92(11):5239–43.PubMedCrossRef Bhol K, Natarajan K, Nagarwalla N, Mohimen A, Aoki V, Ahmed AR. Correlation of peptide specificity and IgG subclass with pathogenic and nonpathogenic autoantibodies in pemphigus vulgaris: a model for autoimmunity. Proc Natl Acad Sci USA. 1995;92(11):5239–43.PubMedCrossRef
Metadata
Title
Determination of Human Anticytokine Autoantibody Profiles Using a Particle-Based Approach
Authors
Li Ding
Allen Mo
Kamonwan Jutivorakool
Minjal Pancholi
Steven M. Holland
Sarah K. Browne
Publication date
01-04-2012
Publisher
Springer US
Published in
Journal of Clinical Immunology / Issue 2/2012
Print ISSN: 0271-9142
Electronic ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-011-9621-8

Other articles of this Issue 2/2012

Journal of Clinical Immunology 2/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.